Connor, Clark & Lunn Investment Management Ltd.

Position in KURA — Kura Oncology, Inc.

CIK 1596800 VANCOUVER, A1

Position in KURA

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$6,508,853

+$81,901 QoQ

Shares Held

800,597

+29.4% QoQ

Ownership

0.902%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. KURA ranks #27 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,508,853	800,597	+29.4%	Shares	Sole	2026-05-11
2025-12-31	$6,426,952	618,571	+69.5%	Shares	Sole	2026-02-10
2025-09-30	$3,229,648	364,932	+1130.6%	Shares	Sole	2025-11-13
2024-09-30	$579,458	29,655	+35.2%	Shares	Sole	2024-11-08
2024-06-30	$451,600	21,933	+15.9%	Shares	Sole	2024-08-09
2023-12-31	$272,026	18,917	-64.5%	Shares	Sole	2024-02-09
2022-09-30	$727,258	53,240	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.